STE

STERIS plc (STE) | Rumor.io

STERIS

STE

Attention (50-day avg)0%

Attention rank (50-day avg)#2,473

Bullish sentiment (50-day avg)100%

Price to earnings ratio25.6

Market capitalization20.6B

Earnings per share8.19

Dividend yield (TTM)1.32%

Revenue (annual)5.9B

Net income (annual)785.1M

Social

What share of all stock conversation is about STE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% +0

May 19

STE's Steramist technology is mentioned as a potential solution for the Ebola threat, with EPA and CDC supporting it.
The World Health Organization is encouraged to take action on this threat.
STE's product Steramist is highlighted as a tool that can help combat the Ebola virus.

Generated by AI

Sentiment

Of the messages about STE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	90% -1.79
Bearish	—	—	—	10% +1.79

Topics

Of the messages about STE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	58.73%	78.56%
Analysts	—	—	20.63%	0.41%
Macro	—	—	20.63%	18.05%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.25%
Technical Analysis	—	—	0%	2.73%

Earnings· Aug 8

Steris plc ($STE) reported FQ1 earnings of $1.00 EPS, beating estimates by $0.02, and $638.76M in revenue, in-line with expectations.
The company reaffirmed its FY19 guidance of $4.63-4.75 EPS and boosted its dividend.
Since the last earnings report, $STE stock has gained 18%, and the company will report its next earnings on August 8 before the open.

Announcements· Jan 12

STERIS plc ($STE) is acquiring Cantel Medical Corp. ($CMD) in a cash and stock deal valued at $4.6 billion, with a purchase price of approximately $84.66 per share.
The acquisition is expected to have less overlap than initially thought, according to Keybanc, and will be completed through a merger agreement.
Shares of Cantel Medical jumped after the announcement, with the company's stock price increasing by 1.3% pre-market, as investors reacted to the news of the acquisition.

Macro· Feb 28

STE's stock is down 20% YTD, affecting its valuation multiples in the medical equipment sector.
Analysts expect STE's growth to slow down in the next quarter due to increased competition in the sterilization market.
STE's acquisition of Cantel Medical is expected to close in Q2, expanding its presence in the medical equipment market.

Generated by AI

Community

Of the messages about STE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	16.08%	10.75%
Newcomers	—	—	83.92%	89.25%

Regulars· May 15

STE shares have seen a 8.03% price increase to $245.77, sparking attention from the investment community.
STE's quarterly results show strong performance in the AST and Healthcare segments, with adjusted EPS of $2.74, revenue of $1.5B, and net income of $146.5M.
STE's focus on sterilization products for hospitals has driven its growth, with a strong weekly chart showing a bullish trend.

Newcomers· May 15

Newcomers are focusing on Steris' (STE) strong Q4 life sciences revenue, which beat analyst estimates.
The company's FY25 operating margin and earnings are finishing on a high note, with impressive upside and solid, balanced revenue performance.
Steris' (+8% gain) is surprising the market, riding a wave of medical demand, with the CEO's revenue report $0.01 billion above estimates.

Generated by AI

News

Also Discussed

Investors talking about STE also mention

#	Name	Attention
1	PKI - PerkinElmer, Inc.	——
2	CONMED CorporationCNMD	0%new
3	Mettler-Toledo International Inc.MTD	0%new
4	PWM - Prestige Wealth Inc.	——
5	GraniteShares Autocallable SMCI ETFSCA	0%0
6	CI&T Inc. Class A Common SharesCINT	0%new
7	Vor Biopharma Inc.VOR	0%new
8	Labcorp Holdings Inc.LH	0%0
9	ATCO - Atlas Corp.	——
10	Locafy LimitedLCFY	0%new

STERIS plc

Healthcare
Medical Devices

STERIS plc is a global healthcare and life sciences company that provides infection prevention and other procedural products and services. The company focuses on helping hospitals, surgery centers, and other medical facilities maintain sterile, safe environments through a broad portfolio of capital equipment, consumables, and technical services. Its Healthcare-related offerings include sterilizers, washer-disinfectors, operating room and endoscopy workflow equipment, connectivity solutions, and infection-prevention chemistries and accessories, along with installation, maintenance, and repair services. Through its Applied Sterilization Technologies operations, STERIS supplies contract sterilization, laboratory testing, and packaging validation services to medical device and pharmaceutical manufacturers, supporting regulatory compliance in highly controlled settings. Its Life Sciences activities provide contamination-control equipment, sterilization and decontamination systems, and support services to biopharmaceutical, biotechnology, and research customers worldwide. Founded in 1985 and headquartered in Dublin, Ireland, with major operational presence in Mentor, Ohio, STERIS plc plays a central role in the infrastructure of modern healthcare and regulated manufacturing by enabling reliable infection prevention and sterile processing.

Website

Location

5960 Heisley Road

Mentor, OH, 44060

United States

Social

What share of all stock conversation is about STE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% +0

May 19

STE's Steramist technology is mentioned as a potential solution for the Ebola threat, with EPA and CDC supporting it.
The World Health Organization is encouraged to take action on this threat.
STE's product Steramist is highlighted as a tool that can help combat the Ebola virus.

Generated by AI

Sentiment

Of the messages about STE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	90% -1.79
Bearish	—	—	—	10% +1.79

Topics

Of the messages about STE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	58.73%	78.56%
Analysts	—	—	20.63%	0.41%
Macro	—	—	20.63%	18.05%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.25%
Technical Analysis	—	—	0%	2.73%

Earnings· Aug 8

Steris plc ($STE) reported FQ1 earnings of $1.00 EPS, beating estimates by $0.02, and $638.76M in revenue, in-line with expectations.
The company reaffirmed its FY19 guidance of $4.63-4.75 EPS and boosted its dividend.
Since the last earnings report, $STE stock has gained 18%, and the company will report its next earnings on August 8 before the open.

Announcements· Jan 12

STERIS plc ($STE) is acquiring Cantel Medical Corp. ($CMD) in a cash and stock deal valued at $4.6 billion, with a purchase price of approximately $84.66 per share.
The acquisition is expected to have less overlap than initially thought, according to Keybanc, and will be completed through a merger agreement.
Shares of Cantel Medical jumped after the announcement, with the company's stock price increasing by 1.3% pre-market, as investors reacted to the news of the acquisition.

Macro· Feb 28

STE's stock is down 20% YTD, affecting its valuation multiples in the medical equipment sector.
Analysts expect STE's growth to slow down in the next quarter due to increased competition in the sterilization market.
STE's acquisition of Cantel Medical is expected to close in Q2, expanding its presence in the medical equipment market.

Generated by AI

Community

Of the messages about STE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	16.08%	10.75%
Newcomers	—	—	83.92%	89.25%

Regulars· May 15

STE shares have seen a 8.03% price increase to $245.77, sparking attention from the investment community.
STE's quarterly results show strong performance in the AST and Healthcare segments, with adjusted EPS of $2.74, revenue of $1.5B, and net income of $146.5M.
STE's focus on sterilization products for hospitals has driven its growth, with a strong weekly chart showing a bullish trend.

Newcomers· May 15

Newcomers are focusing on Steris' (STE) strong Q4 life sciences revenue, which beat analyst estimates.
The company's FY25 operating margin and earnings are finishing on a high note, with impressive upside and solid, balanced revenue performance.
Steris' (+8% gain) is surprising the market, riding a wave of medical demand, with the CEO's revenue report $0.01 billion above estimates.

Generated by AI

STERIS

Social

May 19

Earnings· Aug 8

Announcements· Jan 12

Macro· Feb 28

Regulars· May 15

Newcomers· May 15

Steris PLC stock underperforms Friday when compared to competitors

STERIS Stock: Is STE Underperforming the Healthcare Sector?

Steris PLC stock underperforms Tuesday when compared to competitors

Steris PLC stock outperforms competitors on strong trading day

Steris PLC stock underperforms Thursday when compared to competitors

Steris PLC stock underperforms Wednesday when compared to competitors

Also Discussed

STERIS plc

Company Information

Location

Steris PLC stock underperforms Friday when compared to competitors

STERIS Stock: Is STE Underperforming the Healthcare Sector?

Steris PLC stock underperforms Tuesday when compared to competitors

Steris PLC stock outperforms competitors on strong trading day

Steris PLC stock underperforms Thursday when compared to competitors

Steris PLC stock underperforms Wednesday when compared to competitors

Also Discussed

Social

May 19

Earnings· Aug 8

Announcements· Jan 12

Macro· Feb 28

Regulars· May 15

Newcomers· May 15